This inventor holds 1 USPTO granted patent. Top assignee: Biochem Therapeutics Incorporated. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Wei Wang - Innovator in Antiviral Compounds
Introduction
Wei Wang is a notable inventor based in Pierrefonds, Canada. He has made significant contributions to the field of antiviral research, particularly in the development of compounds that inhibit cytomegalovirus (CMV). His work is crucial in the ongoing fight against viral infections in mammals.
Latest Patents
Wei Wang holds a patent for "Cytomegalovirus inhibiting compounds." This invention relates to heterocyclic compounds that exhibit antiviral activity. The compounds described in his patent are particularly useful in the therapy and prophylaxis of cytomegalovirus infection in mammals.
Career Highlights
Wei Wang is associated with Biochem Therapeutics Incorporated, where he applies his expertise in antiviral research. His innovative approach to developing antiviral compounds has positioned him as a key figure in his field.
Collaborations
Wei Wang has collaborated with notable colleagues, including Haolun Jin and Laval C Chan. These partnerships have enhanced the research and development of antiviral therapies.
Conclusion
Wei Wang's contributions to antiviral research, particularly through his patent on cytomegalovirus inhibiting compounds, highlight his role as an important inventor in the field. His work continues to impact the development of effective therapies against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile